Downloads

Email from 19 December 2019 re notification of price disclosure cycle price reductions

Email from 23 December 2019 re notification of price disclosure cycle price reductions

Email 2 from 23 December 2019 re notification of price disclosure cycle price reductions

Email 3 from 23 December 2019 re notification of price disclosure cycle price reductions

Email from 15 January 2020 re notification of price disclosure cycle price reductions

Email 2 from 15 January 2020 re notification of price disclosure cycle price reductions

Email from 31 January 2020 re RPs to resubmit via the PDSU for the 2020 April cycle

Email from 4 February 2020 re RPs to resubmit via the PDSU for the 2020 April cycle

Email from 5 February 2020 re RPs to resubmit via the PDSU for the 2020 April cycle

Email from 6 February 2020 re RPs to resubmit via the PDSU for the 2020 April cycle

Email from 11 February 2020 re Pegfilgrastim injection dispute outcome for price disclosure for the 2020 April cycle

We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.

FOI number: 
1792-2020
FOI release date: 
21 August 2020
Last updated: 
25 August 2020
Publication type: 
Report
Audience: 
General public
Description: 

All documents relating to the drug ‘pegfilgrastim’, with an injection manner of administration, not having a price reduction imposed on the 1 April 2020 Outcomes from Price Disclosure as shown in the National Health (Weighted average disclosed price – April 2020 reduction day) Determination 2019 (PB 103 of 2019) made under subsection 99ADB(4) and paragraph 99ADH(1)(aa) of the National Health Act 1953 (registered on 30 March 2020).